Data search
Results for MligTC455_37444
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
Cumulative graph for MligTC455_37444
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.932 | 6.379 | 0.20858 | 0.84751 | |
| RegionR2 | 1.909 | 6.379 | 0.00024 | 0.00760 | |
| RegionR3 | -0.538 | 6.379 | 0.30719 | 0.84679 | |
| RegionR4 | -0.637 | 6.379 | 0.29056 | 0.60133 | |
| RegionR5 | -0.419 | 6.379 | 0.42213 | 0.78203 | |
| RegionR6 | 0.318 | 6.379 | 0.52389 | 1.00000 | |
| RegionR7 | 0.186 | 6.379 | 0.71123 | 1.00000 | |
| RegionR8 | 0.113 | 6.379 | 0.83480 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.3 | 6.379 | 0.72910 | 1.00000 | |
| RegenerationR2 | -2.473 | 6.379 | 0.00052 | 0.03106 | |
| RegenerationR3 | -1.705 | 6.379 | 0.01467 | 0.22164 | |
| RegenerationR4 | -1.231 | 6.379 | 0.08114 | 0.45081 | |
| RegenerationR5 | -0.958 | 6.379 | 0.15727 | 0.57840 | |
| RegenerationR6 | -1.775 | 6.379 | 0.01070 | 0.12803 | |
| RegenerationBL | -1.853 | 6.379 | 0.00404 | 0.05701 | |
| RegenerationTP | -0.77 | 6.379 | 0.22061 | 0.66405 |
Genes with expression patterns similar to MligTC455_37444
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
| 2. | MligTC455_47259 | 985 | 20.52 | Mlig455_024978 | Neo: - Age: - Region-enriched R2: 2.522/0.00122 |
4.259 | 0.819 | 0.954 | 0.783 | - | 0.820 | 0.883 | Mlig455_024978 {REF} {Length: 514} {RNA1310_63739.2} {RNA815_33907} | |
| 3. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
3.545 | - | 0.983 | 0.866 | 0.806 | 0.890 | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
| 4. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
2.714 | - | 0.964 | - | - | 0.870 | 0.880 | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
| 5. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
2.713 | 0.966 | 0.943 | - | - | 0.804 | - | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
| 6. | MligTC455_11559 | 259 | 5.4 | Mlig455_058274, Mlig455_070792 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.973 Region-enriched R2: 6.488/0.00000 |
2.699 | - | 0.849 | - | 0.990 | 0.860 | - | Mlig455_058274 {REF} {Length: 786} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} Mlig455_070792 {REF} {Length: 891} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} |
|
| 7. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
2.678 | - | 0.988 | 0.745 | - | 0.945 | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
| 8. | MligTC455_44724 | 186 | 3.88 | Mlig455_024176 | Neo: - Age: - Region-enriched R7: 3.890/0.00870 |
2.674 | - | 0.951 | - | - | 0.860 | 0.863 | Mlig455_024176 {REF} {Length: 967} {RNA1310_84543} {RNA815_47586} | |
| 9. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
2.645 | 0.908 | 0.981 | - | - | 0.756 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
| 10. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
2.636 | 0.941 | - | - | 0.956 | 0.739 | - | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
| 11. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 2.575 | - | 0.993 | 0.709 | - | 0.873 | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
| 12. | MligTC455_25921 | 329 | 6.86 | Mlig455_006703 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-2.996 Region-enriched R2: 6.614/0.00492 |
2.558 | - | 0.875 | 0.727 | - | 0.956 | - | Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1} | |
| 13. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 2.551 | - | 0.967 | 0.709 | - | 0.875 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
| 14. | MligTC455_45542 | 1297 | 27.03 | Mlig455_054862 | Neo: - Age: - Region-specific R2: 3.717 Region-enriched R2: 3.775/0.00000 |
2.525 | 0.708 | - | - | 0.980 | 0.837 | - | Mlig455_054862 {REF} {Length: 827} {RNA1509_22827, RNA1509_33579} {RNA1310_53394, RNA1509_22827, RNA1509_33579} {RNA1509_22827, RNA1509_33579, RNA815_31276} | |
| 15. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 2.466 | - | 0.953 | - | - | 0.772 | 0.741 | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
| 16. | MligTC455_27334 | 8215 | 171.14 | Mlig455_016712, Mlig455_029695, Mlig455_054619 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.862/0.00000 Regeneration-downregulated R2: -6.166 Regeneration-depleted R2: -6.166 |
GNAI1 | 2.443 | - | - | 0.710 | - | 0.979 | 0.754 | Mlig455_016712 {REF} {Length: 1973} {Pfam: G-protein alpha subunit [PF00503.22, score=406.7]; ADP-ribosylation factor family [PF00025.23, score=55.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.9]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.7]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=484, Expect=3e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=477, Expect=1e-168]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=473, Expect=4e-167]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=484, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=480, Expect=4e-170]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=471, Expect=2e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=469, Expect=1e-165]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=439, Expect=6e-154]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=593, Expect=0.0]} {RNA1509_45426} {RNA1310_25155} {RNA815_14897.2} Mlig455_029695 {REF} {Length: 555} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_2874, RNA1509_3945, RNA1509_46274} {RNA1310_102625.1, RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274, RNA815_20834} Mlig455_054619 {REF} {Length: 911} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=36.2]} {RNA1509_40708} {RNA1310_26224} {RNA815_14744.1} |
| 17. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 2.402 | - | 0.987 | 0.709 | - | 0.706 | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
| 18. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
1.897 | - | 0.973 | - | - | 0.924 | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
| 19. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 1.896 | - | 0.977 | - | - | 0.919 | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
| 20. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 1.892 | - | 0.965 | - | - | 0.927 | - | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
| 21. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1.883 | - | 0.987 | - | - | 0.896 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
| 22. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
1.883 | - | 0.987 | - | - | 0.896 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
| 23. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
1.875 | - | 0.987 | - | - | 0.888 | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
| 24. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
1.874 | - | 0.987 | - | - | 0.887 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
| 25. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
1.872 | - | 0.986 | - | - | 0.886 | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
| 26. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 1.871 | - | 0.994 | - | - | 0.877 | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
| 27. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
1.868 | - | 0.987 | - | - | 0.881 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
| 28. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.863 | - | 0.987 | - | - | 0.876 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
| 29. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.863 | - | 0.989 | - | - | 0.874 | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
| 30. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.861 | - | 0.982 | - | - | 0.879 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 31. | MligTC455_17474 | 764 | 15.92 | Mlig455_011194, Mlig455_011222, Mlig455_024747 | Neo: - Age: Down-Up-Up Region-enriched R6: 4.238/0.01164 |
1.859 | 0.952 | - | - | 0.907 | - | - | Mlig455_011194 {REF} {Length: 662} {RNA1509_53854} {RNA1310_31915} {RNA815_45583} Mlig455_011222 {REF} {Length: 1027} {RNA1509_53854} {RNA1310_31915, RNA1509_53854} {RNA1509_53854, RNA815_45583} Mlig455_024747 {REF} {Length: 639} {RNA1509_53854} {RNA1310_35845} {RNA815_45583} |
|
| 32. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 1.852 | - | - | - | 0.985 | 0.867 | - | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
| 33. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.852 | - | 0.985 | - | - | 0.867 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
| 34. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 1.852 | - | 0.961 | - | - | 0.891 | - | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
| 35. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
1.844 | - | 0.986 | - | - | 0.858 | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
| 36. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
1.84 | - | 0.989 | - | - | 0.851 | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
| 37. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
1.838 | - | 0.976 | - | - | 0.862 | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
| 38. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.838 | - | 0.968 | - | - | 0.870 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
| 39. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1.829 | - | 0.987 | - | - | - | 0.842 | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
| 40. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.817 | - | - | - | 0.988 | 0.829 | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
| 41. | MligTC455_41644 | 1214 | 25.28 | Mlig455_036599, Mlig455_057748, Mlig455_057750 | Neo: - Age: - Region-specific R2: 4.114 Region-enriched R2: 2.969/0.00052 Regeneration-downregulated BL: -8.163 Regeneration-depleted BL: -8.163 |
1.816 | 0.956 | - | - | - | 0.860 | - | Mlig455_036599 {REF} {Length: 673} {RNA1509_43529} {RNA1310_60851, RNA1509_43529} {RNA1509_43529, RNA815_37406} Mlig455_057748 {REF} {Length: 702} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} Mlig455_057750 {REF} {Length: 401} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} |
|
| 42. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.815 | - | 0.978 | - | - | 0.837 | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
| 43. | MligTC455_36566 | 40 | 0.83 | Mlig455_053263 | Neo: - Age: - Region-enriched R2: 4.823/0.01830 |
1.809 | - | 0.979 | - | - | 0.830 | - | Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871} | |
| 44. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 1.803 | - | - | - | 0.950 | 0.853 | - | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
| 45. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.799 | - | 0.983 | - | - | 0.816 | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
| 46. | MligTC455_42240 | 80 | 1.66 | Mlig455_038267 | Neo: - Age: Down-Up-Down |
1.798 | - | 0.979 | - | - | 0.819 | - | Mlig455_038267 {REF} {Length: 989} {RNA1310_36501} {RNA815_32545} | |
| 47. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
1.794 | - | 0.973 | - | - | 0.821 | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
| 48. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
1.793 | - | - | - | 0.959 | 0.834 | - | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
| 49. | MligTC455_17445 | 888 | 18.5 | Mlig455_000400 | Neo: - Age: logFC(26M/2M)=0.513 Region-specific R2: 4.076 Region-enriched R2: 3.306/0.00000 |
1.788 | 0.827 | - | - | - | 0.961 | - | Mlig455_000400 {REF} {Length: 711} {RNA1509_36036, RNA1509_39429} {RNA1310_64870, RNA1509_36036, RNA1509_39429} {RNA1509_36036, RNA1509_39429, RNA815_46241} | |
| 50. | MligTC455_48927 | 803 | 16.73 | Mlig455_054812 | Neo: - Age: Down-Up-Up |
1.786 | - | - | - | 0.973 | 0.813 | - | Mlig455_054812 {REF} {Length: 627} {Pfam: Pancreatic hormone peptide [PF00159.20, score=68.1]; Glutaredoxin 2, C terminal domain [PF04399.15, score=21.5]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [RH, Score=42.4, Expect=4e-06]} {RNA1509_56617} {RNA1310_62193} {RNA815_34296.1} | |
| 51. | MligTC455_31172 | 195 | 4.06 | Mlig455_028354 | Neo: - Age: - Region-enriched R5: 4.005/0.04475 |
1.769 | - | 0.954 | - | - | 0.815 | - | Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412} | |
| 52. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
1.753 | - | 0.987 | - | - | 0.766 | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
| 53. | MligTC455_44525 | 3358 | 69.96 | Mlig455_004678, Mlig455_004741, Mlig455_004755, Mlig455_004840 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.742 Region-enriched R2: 10.296/0.00000 |
1.748 | - | - | - | 0.783 | 0.965 | - | Mlig455_004678 {REF} {Length: 845} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004741 {REF} {Length: 961} {RNA1509_25712} {RNA1310_68954.1} {RNA815_35323} Mlig455_004755 {REF} {Length: 1059} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004840 {REF} {Length: 918} {RNA1509_25712, RNA1509_29691} {RNA1310_68954.2, RNA1509_25712, RNA1509_29691} {RNA1509_25712, RNA1509_29691, RNA815_35323} |
|
| 54. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1.742 | - | 0.987 | - | - | 0.755 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
| 55. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
1.74 | - | 0.972 | - | - | 0.768 | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
| 56. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
1.737 | 0.770 | - | - | 0.967 | - | - | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
| 57. | MligTC455_40882 | 435 | 9.07 | Mlig455_059173 | Neo: - Age: - |
GAD1 | 1.724 | 0.965 | - | - | - | 0.759 | - | Mlig455_059173 {REF} {Length: 3488} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=391.1]} {Human: ENSG00000128683, GAD1, glutamate decarboxylase 1, [RH, Score=659, Expect=0.0]} {Mouse: ENSMUSG00000070880, Gad1, glutamate decarboxylase 1, [RH, Score=659, Expect=0.0]} {Dmel: FBgn0004516, Gad1, Glutamic acid decarboxylase 1, [RH, Score=558, Expect=0.0]} {Celegans: WBGene00006762, unc-25, Glutamic acid decarboxylase, [RH, Score=595, Expect=0.0]} {Smed: dd_Smed_v6_12653_0_1, dd_Smed_v6_12653_0_1, [RH, Score=666, Expect=0.0]} {RNA1509_17310} {RNA1310_9376} {RNA815_16779} |
| 58. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 1.719 | - | - | - | 0.978 | 0.741 | - | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
| 59. | MligTC455_47793 | 2842 | 59.22 | Mlig455_041989 | Neo: - Age: - Region-specific R2: 2.763 Region-enriched R2: 2.438/0.00012 |
1.715 | 0.761 | - | - | - | 0.954 | - | Mlig455_041989 {REF} {Length: 709} {RNA1509_14790, RNA1509_18883, RNA1509_8027} {RNA1310_58119, RNA1509_14790, RNA1509_18883, RNA1509_8027} {RNA1509_14790, RNA1509_18883, RNA1509_8027, RNA815_32986} | |
| 60. | MligTC455_53252 | 103 | 2.15 | Mlig455_065173 | Neo: - Age: logFC(26M/2M)=0.345 Region-enriched R2: 3.909/0.00866 |
SYT7 | 1.712 | 0.959 | - | - | - | 0.753 | - | Mlig455_065173 {REF} {Length: 2245} {Pfam: C2 domain [PF00168.32, score=157.7]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=262, Expect=2e-80]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=253, Expect=3e-78]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=231, Expect=2e-73]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=180, Expect=8e-54]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=196, Expect=2e-58]} {RNA1509_49257} {RNA1310_13701, RNA1509_49257} {RNA1509_49257, RNA815_8339} |
| 61. | MligTC455_20428 | 37 | 0.78 | Mlig455_050428 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.829/0.00010 |
LRRN3 | 1.706 | - | 0.956 | - | - | 0.750 | - | Mlig455_050428 {REF} {Length: 10329} {Pfam: Leucine rich repeat [PF13855.8, score=96.2]; Leucine Rich repeats (2 copies) [PF12799.9, score=63.4]; Immunoglobulin domain [PF13927.8, score=44.7]; Immunoglobulin I-set domain [PF07679.18, score=41.3]; Immunoglobulin domain [PF00047.27, score=31.4]; Leucine-rich repeat [PF14580.8, score=24.8]; Immunoglobulin V-set domain [PF07686.19, score=23.1]; Immunoglobulin domain [PF13895.8, score=22.9]; Leucine Rich Repeat [PF00560.35, score=20.8]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [RH, Score=114, Expect=2e-25]; ENSG00000174482, LINGO2, leucine rich repeat and Ig domain containing 2, [RH, Score=112, Expect=3e-25]; ENSG00000175928, LRRN1, leucine rich repeat neuronal 1, [RH, Score=111, Expect=2e-24]} {Mouse: ENSMUSG00000036295, Lrrn3, leucine rich repeat protein 3, neuronal, [RH, Score=113, Expect=2e-25]; ENSMUSG00000045083, Lingo2, leucine rich repeat and Ig domain containing 2, [RH, Score=110, Expect=1e-24]; ENSMUSG00000034648, Lrrn1, leucine rich repeat protein 1, neuronal, [RH, Score=108, Expect=5e-24]} {Dmel: FBgn0032479, CG16974, [Score=89.0, Expect=1e-17]} {Celegans: WBGene00020649, sma-10, Leucine-rich repeats and immunoglobulin-like domains protein sma-10, [Score=73.6, Expect=4e-13]} {RNA1509_34876} {RNA1310_313, RNA1509_34876} {RNA1509_34876, RNA815_2616} |
| 62. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
1.701 | - | 0.960 | - | - | 0.741 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
| 63. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
1.697 | - | 0.973 | 0.724 | - | - | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
| 64. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 1.691 | - | 0.976 | - | - | 0.715 | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
| 65. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.686 | - | 0.979 | - | - | 0.707 | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
| 66. | MligTC455_25242 | 55 | 1.15 | Mlig455_046799, Mlig455_063518 | Neo: - Age: - Region-enriched R2: 5.810/0.00185 |
DOC2B, RPH3A | 1.682 | - | 0.958 | - | - | 0.724 | - | Mlig455_046799 {REF} {Length: 1832} {Pfam: C2 domain [PF00168.32, score=147.1]} {Human: ENSG00000272636, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000272670, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000089169, RPH3A, rabphilin 3A, [Score=237, Expect=3e-71]; ENSG00000149927, DOC2A, double C2 domain alpha, [Score=234, Expect=1e-72]} {Mouse: ENSMUSG00000020848, Doc2b, double C2, beta, [Score=243, Expect=3e-76]; ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=239, Expect=1e-74]; ENSMUSG00000029608, Rph3a, rabphilin 3A, [Score=237, Expect=4e-71]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=188, Expect=2e-55]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=216, Expect=4e-62]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=239, Expect=5e-73]} {RNA1310_26201} {RNA815_12702} Mlig455_063518 {REF} {Length: 2724} {Pfam: C2 domain [PF00168.32, score=147.7]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=191, Expect=1e-54]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=219, Expect=4e-63]} {Smed: dd_Smed_v6_12977_0_2, dd_Smed_v6_12977_0_2, [Score=241, Expect=1e-73]} {RNA1310_26201} {RNA815_12702} |
| 67. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
1.68 | - | 0.721 | - | 0.959 | - | - | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
| 68. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
1.671 | - | 0.962 | 0.709 | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
| 69. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
1.667 | - | 0.958 | 0.709 | - | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
| 70. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
0.994 | - | 0.994 | - | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
| 71. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
| 72. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
| 73. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
| 74. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.987 | - | 0.987 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
| 75. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
| 76. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
| 77. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
| 78. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.986 | - | 0.986 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
| 79. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.986 | - | 0.986 | - | - | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
| 80. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.986 | - | 0.986 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
| 81. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
| 82. | MligTC455_47792 | 666 | 13.88 | Mlig455_041913 | Neo: - Age: - Region-specific R2: 4.721 Region-enriched R2: 5.442/0.00000 |
0.985 | - | - | - | - | 0.985 | - | Mlig455_041913 {REF} {Length: 603} {RNA1509_14790} {RNA1310_58119} {RNA815_32986} | |
| 83. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
| 84. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
| 85. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.98 | - | 0.980 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
| 86. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.979 | - | 0.979 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
| 87. | MligTC455_05659 | 9 | 0.19 | Mlig455_000779 | Neo: - Age: - |
0.978 | - | 0.978 | - | - | - | - | Mlig455_000779 {REF} {Length: 525} {RNA1509_14736} {RNA1310_6965} {RNA815_41421} | |
| 88. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.977 | - | 0.977 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
| 89. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.976 | - | 0.976 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
| 90. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.976 | - | 0.976 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
| 91. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.976 | - | 0.976 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
| 92. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.976 | - | 0.976 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
| 93. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.972 | - | 0.972 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
| 94. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 0.971 | - | 0.971 | - | - | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
| 95. | MligTC455_44955 | 757 | 15.78 | Mlig455_029614 | Neo: Int S/G2/M Age: - Region-specific R2: 8.255 Region-enriched R2: 9.875/0.00000 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_029614 {REF} {Length: 499} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1, RNA1509_17163} {RNA1509_17163, RNA815_41767} | |
| 96. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.971 | - | 0.971 | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
| 97. | MligTC455_52821 | 1046 | 21.79 | Mlig455_006091 | Neo: - Age: - |
P4HA3 | 0.971 | - | - | - | 0.971 | - | - | Mlig455_006091 {REF} {Length: 2559} {Pfam: Prolyl 4-Hydroxylase alpha-subunit, N-terminal region [PF08336.13, score=19.9]} {Human: ENSG00000149380, P4HA3, prolyl 4-hydroxylase subunit alpha 3, [Score=50.8, Expect=7e-06]} {Dmel: FBgn0039783, PH4alphaNE2, prolyl-4-hydroxylase-alpha NE2, [Score=59.3, Expect=7e-09]} {RNA1509_18750} {RNA1310_8314.1, RNA1509_18750} {RNA1509_18750, RNA815_2755} |
| 98. | MligTC455_16201 | 175 | 3.64 | Mlig455_041123, Mlig455_041179 | Neo: - Age: Down-Up-Up |
0.966 | 0.966 | - | - | - | - | - | Mlig455_041123 {REF} {Length: 2988} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=40.5]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=74.7, Expect=7e-16]} {RNA1509_42904} {RNA1310_20004} {RNA815_27472.1} Mlig455_041179 {REF} {Length: 2106} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=40.5]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=74.7, Expect=7e-16]} {RNA1509_54374} {RNA1310_48801} {RNA815_35149} |
|
| 99. | MligTC455_14059 | 24 | 0.5 | Mlig455_037086 | Neo: - Age: - Region-enriched R2: 8.935/0.00338 |
0.964 | - | 0.964 | - | - | - | - | Mlig455_037086 {REF} {Length: 1622} {Pfam: Galactosyltransferase [PF01762.23, score=18.6]} {RNA1310_57689} {RNA815_57743} | |
| 100. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} |
There are 16 more genes with r >= 0.95